Aptahem AB (publ) (APTA.ST)

SEK 1.14

(-0.87%)

Total Debt Summary of Aptahem AB (publ)

  • Aptahem AB (publ)'s latest annual total debt in 2023 was 5 Million SEK , down 0.0% from previous year.
  • Aptahem AB (publ)'s latest quarterly total debt in 2024 Q2 was - SEK , down 0.0% from previous quarter.
  • Aptahem AB (publ) reported annual total debt of - SEK in 2022, down 0.0% from previous year.
  • Aptahem AB (publ) reported annual total debt of - SEK in 2021, down 0.0% from previous year.
  • Aptahem AB (publ) reported quarterly total debt of - SEK for 2024 Q1, down -100.0% from previous quarter.
  • Aptahem AB (publ) reported quarterly total debt of - SEK for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of Aptahem AB (publ) (2023 - 2016)

Historical Annual Total Debt of Aptahem AB (publ) (2023 - 2016)

Year Total Debt Total Debt Growth
2023 5 Million SEK 0.0%
2022 - SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%

Peer Total Debt Comparison of Aptahem AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 68.938%
Ziccum AB (publ) 857 Thousand SEK -483.431%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK -0.422%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 79.582%
Genovis AB (publ.) 79.32 Million SEK 93.696%
Intervacc AB (publ) 181 Thousand SEK -2662.431%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 75.741%
Active Biotech AB (publ) 3 Million SEK -66.667%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 91.708%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 92.998%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 36.127%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -1079.245%
Egetis Therapeutics AB (publ) 108.6 Million SEK 95.396%
Karolinska Development AB (publ) 3.07 Million SEK -62.866%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK -93.798%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -400.0%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.489%
Camurus AB (publ) 24.5 Million SEK 79.598%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 81.862%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.423%
Cyxone AB (publ) 858 Thousand SEK -482.751%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK -192.227%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 86.416%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -650.751%
SynAct Pharma AB 637 Thousand SEK -684.929%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -488.235%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -183.93%
BioInvent International AB (publ) 23.24 Million SEK 78.489%
Alzinova AB (publ) 800 Thousand SEK -525.0%
Oncopeptides AB (publ) 106.48 Million SEK 95.305%
Pila Pharma AB (publ) 773.08 Thousand SEK -546.764%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 94.49%
Diamyd Medical AB (publ) 30.67 Million SEK 83.698%
Xbrane Biopharma AB (publ) 231.47 Million SEK 97.84%
Ascelia Pharma AB (publ) 1.06 Million SEK -371.254%
Diagonal Bio AB (publ) - SEK -Infinity%